- Home
- OXBR vs TRAW Comparison
OXBR vs TRAW Comparison
Compare OXBR & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXBR
- TRAW
- Stock Information
- Founded
- OXBR 2013
- TRAW 1998
- Country
- OXBR Cayman Islands
- TRAW United States
- Employees
- OXBR N/A
- TRAW N/A
- Industry
- OXBR Property-Casualty Insurers
- TRAW
- Sector
- OXBR Finance
- TRAW
- Exchange
- OXBR Nasdaq
- TRAW NYSE
- Market Cap
- OXBR 15.8M
- TRAW 15.0M
- IPO Year
- OXBR 2014
- TRAW 2013
- Fundamental
- Price
- OXBR $2.74
- TRAW $4.99
- Analyst Decision
- OXBR
- TRAW
- Analyst Count
- OXBR 0
- TRAW 0
- Target Price
- OXBR N/A
- TRAW N/A
- AVG Volume (30 Days)
- OXBR 14.1K
- TRAW 9.9K
- Earning Date
- OXBR 11-13-2024
- TRAW 11-14-2024
- Dividend Yield
- OXBR N/A
- TRAW N/A
- EPS Growth
- OXBR N/A
- TRAW N/A
- EPS
- OXBR N/A
- TRAW N/A
- Revenue
- OXBR N/A
- TRAW $226,000.00
- Revenue This Year
- OXBR N/A
- TRAW $2.90
- Revenue Next Year
- OXBR N/A
- TRAW N/A
- P/E Ratio
- OXBR N/A
- TRAW N/A
- Revenue Growth
- OXBR N/A
- TRAW N/A
- 52 Week Low
- OXBR $0.87
- TRAW $4.44
- 52 Week High
- OXBR $3.72
- TRAW $27.50
- Technical
- Relative Strength Index (RSI)
- OXBR 52.49
- TRAW 41.74
- Support Level
- OXBR $2.41
- TRAW $4.92
- Resistance Level
- OXBR $2.97
- TRAW $5.96
- Average True Range (ATR)
- OXBR 0.22
- TRAW 0.29
- MACD
- OXBR -0.01
- TRAW 0.12
- Stochastic Oscillator
- OXBR 55.93
- TRAW 10.19
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.